Clinical Trial Update: PSMA PET Combined With MRI for the Detection of PCa [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update indicating recruitment is ongoing for using PSMA PET combined with MRI to detect prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited | Conditions: PCA, Prostate Cancer | Phase 3 | Status: RECRUITING